Tumor-Infiltrating CD8+ Lymphocytes Effect on Clinical Outcome of Muco-Cutaneous Melanoma, Indian J. Dermatol, vol.60, p.212, 2015. ,
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer, Proc. Natl. Acad. Sci, vol.102, pp.18538-18543, 2005. ,
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome, Science, vol.313, 1960. ,
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma, Proc. Natl. Acad. Sci, vol.104, pp.3967-3972, 2007. ,
Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer, J. Clin. Oncol, vol.29, 1949. ,
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer, Nat. Commun, vol.8, 2017. ,
, Epithelial Defence by ?? T Cells. Int. Arch. Allergy Immunol, vol.137, pp.73-81, 2005.
Cytomegalovirus and tumor stress surveillance by binding of a human ?? T cell antigen receptor to endothelial protein C receptor, Nat. Immunol, vol.13, pp.872-879, 2012. ,
V?9V?2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas, Cancer Immunol. Immunother, vol.57, pp.531-539, 2007. ,
Characterization of Human ?? T Lymphocytes Infiltrating Primary Malignant Melanomas, PLoS ONE, vol.7, 2012. ,
V?9V?2 T Cell Response to Colon Carcinoma Cells, J. Immunol, vol.175, pp.5481-5488, 2005. ,
In vivo manipulation of V?9V?2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients, Clin. Exp. Immunol, vol.161, pp.290-297, 2010. ,
Tumour-infiltrating gamma/delta T-lymphocytes are correlated with a brief disease-free interval in advanced ovarian serous carcinoma, Ann. Oncol, vol.16, pp.590-596, 2005. ,
Current Advances in ?? T Cell-Based Tumor Immunotherapy, Front. Immunol, vol.8, issue.8, 2017. ,
Role of gamma-delta T-cells in cancer, Clin. Transl. Oncol, vol.14, pp.891-895, 2012. ,
Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local, Front. Immunol, vol.9, issue.9, 2018. ,
In vivo expansion and activation of ?? T cells as immunotherapy for refractory neuroblastoma, Medicine, vol.95, 2016. ,
Human gamma delta T cells: Evolution and ligand recognition, Cell. Immunol, vol.296, pp.31-40, 2015. ,
?? T cell effector functions: A blend of innate programming and acquired plasticity, Nat. Rev. Immunol, vol.10, pp.467-478, 2010. ,
Tumor-Infiltrating Π3 δT Lymphocytes: Pathogenic Role, Clinical Significance, and Differential Programing in the Tumor Microenvironment, Front. Immunol, vol.5, p.607, 2014. ,
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: Recommendations by an International TILs Working Group, Ann. Oncol, vol.26, pp.259-271, 2014. ,
Identification of a regulatory Vdelta1 gamma delta T cell subpopulation expressing CD73 in human breast cancer, J. Leukoc. Biol, vol.107, pp.1057-1067, 2020. ,
The principles of cancer staging, vol.10, p.61, 2016. ,
Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer, Ann. Oncol, vol.27, pp.225-232, 2016. ,
Cancer classification using the Immunoscore: A worldwide task force, J. Transl. Med, vol.10, p.205, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00780742
Immunohistochemical Detection of ?/? T Lymphocytes in Formalin-fixed Paraffin-embedded Tissues, Appl. Immunohistochem. Mol. Morphol, vol.27, pp.581-583, 2019. ,
Strategies in Developing Immunotherapy for Pancreatic Cancer: Recognizing and Correcting Multiple Immune "Defects" in the Tumor Microenvironment, J. Clin. Med, 1472. ,
Tumor-infiltrating ?? T lymphocytes predict clinical outcome in human breast cancer, J. Immunol, vol.189, pp.5029-5036, 2012. ,
Targeting the Molecular Subtypes of Triple Negative Breast Cancer: Understanding the Diversity to Progress the Field, Oncologist, vol.22, pp.1086-1093, 2017. ,
Tumor-derived ?? regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence, J. Immunol, vol.190, pp.2403-2414, 2013. ,
Histological Analysis of ?? T Lymphocytes Infiltrating Human Triple-Negative Breast Carcinomas, Front. Immunol, vol.5, 2014. ,
An innate-like V?1+ ?? T cell compartment in the human breast is associated with remission in triple-negative breast cancer, Sci. Transl. Med, vol.11, 2019. ,
Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer, JAMA Oncol, vol.3, pp.194-201, 2017. ,
The impact of microsatellite stability status in colorectal cancer, Curr. Probl. Cancer, vol.42, pp.548-559, 2018. ,
BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer, British J. Cancer, vol.104, pp.856-862, 2011. ,
The prognostic role of BRAF mutation in metastatic colorectal cancer receiving anti-EGFR monoclonal antibodies: A meta-analysis, PLoS ONE, vol.8, 2013. ,
Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal antibody therapy for RAS wild-type metastatic colorectal cancer, British J. Cancer, vol.112, pp.1888-1894, 2015. ,
Treatment and Survival Outcome of BRAF-Mutated Metastatic Colorectal Cancer: A Retrospective Matched Case-Control Study, Clin. Colorectal Cancer, vol.17, pp.69-76, 2018. ,
Distinctive features of tumor-infiltrating gammadelta T lymphocytes in human colorectal cancer, vol.6, 2017. ,
Immune infiltration in human tumors: A prognostic factor that should not be ignored, Oncogene, vol.29, pp.1093-1102, 2010. ,
Assessment of tumor-infiltrating TCRV?9V?2??lymphocyte abundance by deconvolution of human cancers microarrays, vol.6, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-02472196
Targeting neoantigens to augment antitumour immunity, Nat. Rev. Cancer, vol.17, pp.209-222, 2017. ,
Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer, Proc. Natl. Acad. Sci, vol.116, pp.1692-1697, 2019. ,
The pancreas cancer microenvironment, Clin. Cancer Res, vol.18, pp.4266-4276, 2012. ,
The stromal compartments in pancreatic cancer: Are there any therapeutic targets?, Cancer Lett, vol.343, pp.147-155, 2014. ,
No improvement in long-term survival for epithelial ovarian cancer patients: A population-based study between 1989 and 2014 in the Netherlands, Eur. J. Cancer, vol.88, pp.31-37, 2018. ,
Distribution and functions of ?? T cells infiltrated in the ovarian cancer microenvironment, J. Transl. Med, vol.17, 2019. ,
Functional analysis of TCR ??+T cells in tumour-infiltrating lymphocytes (TIL) of human pancreatic cancer, Clin. Exp. Immunol, vol.93, pp.442-447, 1993. ,
Human Ovarian Tumor Cells Escape ?? T Cell Recognition Partly by Down Regulating Surface Expression of MICA and Limiting Cell Cycle Related Molecules, PLoS ONE, vol.6, 2011. ,
V?6(+) ?? T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages, Proc. Natl. Acad. Sci, vol.111, pp.3562-3570, 2014. ,
IL-17-producing ?? T cells and neutrophils conspire to promote breast cancer metastasis, Nature, vol.522, pp.345-348, 2015. ,
IL-17A Produced by T Cells Promotes Tumor Growth in Hepatocellular Carcinoma, Cancer Res, vol.74, 1969. ,
??T17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer, vol.40, pp.785-800, 2014. ,
Contribution of IL-17-producing ?? T cells to the efficacy of anticancer chemotherapy, J. Exp. Med, vol.208, pp.491-503, 2011. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00576679
Tumor-Infiltrating ?? T Cells Suppress T and Dendritic Cell Function via Mechanisms Controlled by a Unique Toll-like Receptor Signaling Pathway, Immunity, vol.27, pp.334-348, 2007. ,
, ?? T Cells Support Pancreatic Oncogenesis by Restraining ?? T Cell Activation, vol.166, pp.1485-1499, 2016.
,
, This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, © 2020 by the authors. Licensee MDPI